Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,301
Closed -$298K 150
2024
Q3
$298K Sell
10,301
-198
-2% -$5.78K 0.06% 110
2024
Q2
$294K Buy
10,499
+21
+0.2% +$578 0.07% 107
2024
Q1
$291K Buy
10,478
+21
+0.2% +$583 0.08% 106
2023
Q4
$301K Buy
10,457
+18
+0.2% +$544 0.09% 98
2023
Q3
$346K Buy
10,439
+4
+0% +$141 0.12% 85
2023
Q2
$383K Buy
10,435
+13
+0.1% +$506 0.14% 80
2023
Q1
$425K Buy
10,422
+13
+0.1% +$561 0.17% 69
2022
Q4
$533K Sell
10,409
-230
-2% -$11K 0.23% 55
2022
Q3
$466K Buy
10,639
+389
+4% +$18.9K 0.24% 57
2022
Q2
$537K Buy
10,250
+11
+0.1% +$561 0.27% 51
2022
Q1
$530K Buy
10,239
+10
+0.1% +$519 0.23% 64
2021
Q4
$604K Sell
10,229
-42
-0.4% -$2.08K 0.26% 55
2021
Q3
$442K Buy
10,271
+160
+2% +$7.09K 0.2% 63
2021
Q2
$396K Buy
10,111
+2,123
+27% +$82.6K 0.19% 70
2021
Q1
$289K Buy
7,988
+12
+0.2% +$426 0.16% 76
2020
Q4
$294K Sell
7,976
-420
-5% -$15.4K 0.18% 66
2020
Q3
$292K Buy
8,396
+38
+0.5% +$1.33K 0.21% 65
2020
Q2
$259K Buy
8,358
+11
+0.1% +$374 0.2% 66
2020
Q1
$258K Buy
8,347
+223
+3% +$7.6K 0.25% 62
2019
Q4
$302K Buy
8,124
+10
+0.1% +$356 0.25% 45
2019
Q3
$277K Buy
+8,114
New +$295K 0.26% 47

Other funds holding PFE

IFG Advisors's PFE Position: Q4 2024 in Review

IFG Advisors sold out of Pfizer (PFE) in Q4 2024, closing a stake of 10,301 shares — an estimated $298K sold.

IFG Advisors first reported a position in PFE in Q3 2019 and held it in 21 quarters. The position peaked at $604K in Q4 2021. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • IFG Advisors reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • IFG Advisors sold 10,301 Pfizer shares in Q4 2024, an estimated $298K.
  • IFG Advisors first reported a position in Pfizer in Q3 2019 and held it in 21 quarters.
  • IFG Advisors's Pfizer position peaked at $604K in Q4 2021.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on IFG Advisors's 13F filing for Q4 2024, filed 5 Feb 2025.